Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Ductal Adenocarcinoma × mitazalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasms 1 Motor Activity 1 Biliary Tract Neoplasms 1 Advanced Solid Neoplasms 1

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 3 Pancreaticoduodenectomy 2 Oxaliplatin 2 Irinotecan 2 titanium silicide 1 tislelizumab 1 sonidegib 1 paricalcitol 1 mitazalimab 1 lenvatinib 1 ivosidenib 1 glucoraphanin 1 devimistat 1 Transurethral Resection of Prostate 1 Tissue Banks 1 Taxes 1 Specimen Handling 1 Saline Solution 1 S 1 (combination) 1 Ropivacaine 1 Robotic Surgical Procedures 1 Positron Emission Tomography Computed Tomography 1 Parturition 1 PEGPH20 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Losartan 1 Leucovorin 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07199764 2026-03-06

IGNITE

University of Pennsylvania

Phase 2 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡